Clinical Trials Logo

Secondary Liver Cancer clinical trials

View clinical trials related to Secondary Liver Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT05267080 Recruiting - Clinical trials for Primary Liver Cancer

Registry on Percutaneous Electrochemotherapy

RESPECT
Start date: January 25, 2023
Phase:
Study type: Observational [Patient Registry]

The Registry on Percutaneous ElectroChemoTherapy (RESPECT) is a post-market, prospective, non-randomized, observational study aiming at evaluating the effectiveness of percutaneous electrochemotherapy (ECT) for the treatment of liver cancer.

NCT ID: NCT04338685 Completed - Clinical trials for Carcinoma, Hepatocellular

A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases

Start date: July 16, 2020
Phase: Phase 1
Study type: Interventional

Phase I study of RO7119929 given orally to participants with unresectable advanced or metastatic primary liver cancers and other solid tumors with predominant liver involvement. The primary objective of the study is to explore the safety and to determine the maximum tolerated dose (MTD) and/or optimal biologic dose (OBD) of RO7119929 as single agent.

NCT ID: NCT03518632 Completed - Liver Metastases Clinical Trials

Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer (APACHE)

APACHE
Start date: March 27, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to assess the impact of preoperative physical activity on physical capacities of patients undergoing liver resection for primary or secondary liver cancer.

NCT ID: NCT00510627 Withdrawn - Clinical trials for Metastatic Liver Cancer

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases

Prometheus
Start date: August 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether patients treated with Radiofrequency Ablation (RFA) in conjunction with chemotherapy have a better overall survival rate than patients treated with chemotherapy alone.